Evidence map›Paper›PMID 42606388›Full record

ReviewFEMS microbiology reviews2026

The molecular mechanisms of autophagy-virus interactions: from antiviral defense to viral counterstrategies.

Yan-Mei Song, Xiao-Lan Gu, Bi-Feng Yuan, Xue-Jie Yu

Abstract readReview
In one paragraph

Review in FEMS microbiology reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yan-Mei SongSchool of Public Health, Wuhan University, Wuhan 430071, China.
Xiao-Lan GuDepartment of Clinical Laboratory, Gansu Provincial Hospital, Lanzhou, Gansu 730000, China.
Bi-Feng YuanSchool of Public Health, Wuhan University, Wuhan 430071, China.
Xue-Jie YuSchool of Public Health, Wuhan University, Wuhan 430071, China.

Funding

Fund of Gansu Provincial Hospital 23GSSYB-4Gansu Provincial Clinical Research Center for Laboratory Medicine 21JR7RA676National Natural Science Foundation of China 32470155Natural Science Foundation of Gansu Province 24JRRA611Scientific Research Project Fund for Health Industry of Gansu Province GSWSQNPY2025-05
6 · The paper itself

Abstract

Autophagy is a highly conserved cellular degradative pathway in eukaryotes that exerts a dual regulatory role in the host antiviral defense. On the one hand, as an essential component of the host antiviral defense network, autophagy participates in the direct degradation of viral components, synergistically modulates innate immune signaling pathways including TLRs, RLRs, and cGAS-STING, and regulates adaptive immune responses such as MHC class I/II-mediated antigen presentation. On the other hand, diverse viruses have evolved sophisticated immune evasion mechanisms during long-term coevolution with the host. These viruses target key steps of autophagy, including initiation, membrane nucleation, elongation, maturation, and lysosomal fusion, to hijack or suppress the autophagic pathway and facilitate their replication. The regulation of autophagy by different viruses exhibits remarkable molecular specificity. In-depth dissection of these molecular mechanisms underlying autophagy-virus interactions will provide novel insights into the pathogenesis of viral diseases. This review systematically summarizes the core process of autophagy and its multiple regulatory mechanisms in antiviral immunity. We further highlight how viruses employ specific molecular strategies to target distinct stages of autophagy during infection, thereby hijacking the autophagic pathway to complete their replication cycles and pathogenic progression.

Indexed as

AutophagyHost-Pathogen InteractionsVirus DiseasesVirusesAnimalsHumansImmune EvasionImmunity, Innateantiviral immunityautophagyhost-virus interactionimmune evasionviral counterstrategyviral infection

Identifiers

PMID42606388
PMCPMC13525635

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.